Sign In
Buy CVAC
$4.66
+0 (+0%)
At Close: Apr 02, 2026
CureVac ends development of Covid vaccine candidate
04:33pm, Tuesday, 12'th Oct 2021
CureVac CEO Franz Haas joins Closing Bell to discuss why his company discontinued the development of its Covid-19 vaccine. The company's stock fell today on the news.
Why CureVac Stock Is Tumbling Today
11:10am, Tuesday, 12'th Oct 2021
The company is throwing in the towel on its first-generation COVID-19 vaccine candidate.
Why CureVac Shares Are Trading Lower Today
09:42am, Tuesday, 12'th Oct 2021
CureVac NV (NASDAQ: CVAC) is trading lower Tuesday after the company announced it will focus its COVID-19 vaccine development towards the development of second-gen mRNA vaccine candidates in collabor
CureVac to Shift Focus of COVID-19 Vaccine Development to Second-Generation mRNA Technology
07:15am, Tuesday, 12'th Oct 2021
- COVID-19 vaccine efforts to be re-allocated to accelerate the development of second-generation program in collaboration with GSK - First-generation vaccine candidate, CVnCoV, to be withdrawn from re
CureVac stops development of its COVID-19 shot, will focus on new COVID-19 vaccine set for 2022
07:14am, Tuesday, 12'th Oct 2021
Shares of CureVac CVAC, -1.37% tumbled 9.6% in premarket trading on Tuesday after the German biopharmaceutical company said it will scrap development of its COVID-19 vaccine candidate and instead focu
Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks Need a Band-Aid Today
01:16pm, Friday, 01'st Oct 2021
Today, vaccine stocks are taking a massive hit as investors price in the potential effect of oral medications for Covid-19 on this sector. The post Vaccine Stocks: Why MRNA, VXRT, CVAC and NVAX Stocks
CureVac Shares Fall After Cutting COVID-19 Vaccine Production Plans
03:36pm, Tuesday, 14'th Sep 2021
CureVac BV (NASDAQ: CVAC) has canceled contract manufacturing deals for its experimental COVID-19 vaccine with two prospective partners. The Company would terminate agreements with Celonic Group
Why CureVac's Stock Is Down During Today's Session
03:24pm, Tuesday, 14'th Sep 2021
CureVac (NASDAQ:CVAC) shares are trading lower after the company announced its strategic decision to adjust the long-term footprint of the external European manufacturing network for its mRNA produc
Could CureVac's Canceled Deal Spell Trouble for Other mRNA Cancer Vaccines?
07:04am, Friday, 27'th Aug 2021
It isn't likely.
Surprise! Here's the Cheapest COVID Vaccine Stock on the Market Right Now
05:52am, Thursday, 19'th Aug 2021
The least expensive COVID-19 vaccine stock right now isn't one of the leaders in the market -- at least not yet.
CureVac Says Second Covid-19 Vaccine Was Better in Preclinical Test
09:58am, Tuesday, 17'th Aug 2021
CureVac and partner GlaxoSmithKline say CureVac's second-generation Covid-19 vaccine was more effective than its first in a test with monkeys. CureVac's first vaccine was a disappointment.
Boehringer Ingelheim Scraps Lung Cancer Program With CureVac
04:08pm, Monday, 16'th Aug 2021
CureVac NV (NASDAQ: CVAC) disclosed among the COVID-19 vaccine highlights that €465 million oncology partnership with Boehringer Ingelheim had been terminated. CureVac and Boehringer had been wor
Vaccine Stocks: The Latest News Moving BNTX, CVAC, NVAX Stocks Today
03:17pm, Monday, 16'th Aug 2021
Today, investors in vaccine stocks are seeing a lot of red, as investors seem to be taking some risk off the table ahead of Fed tapering. The post Vaccine Stocks: The Latest News Moving BNTX, CVAC, NV
CureVac stock gains after upbeat preclinical data on COVID-19 vaccine candidate on primates
10:30am, Monday, 16'th Aug 2021
Shares of CureVac N.V. CURE, +0.48% gained 0.4% in morning trading Monday, but bucked the selloff in the biotechnology sector and the broader stock market, after the Germany-based company revealed upb
Nio Drops, CureVac Jumps as the Stock Market Slips
08:32am, Monday, 16'th Aug 2021
Stocks look set for a lower open as the pace of growth in China slowed and Afghanistan fell back under Taliban control.
